3
Announcements
Trials
Browse
Landscape
Status
Recruiting
8
Active not recruiting
7
No longer available
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Interventions
Suspensions
2
Powders
2
trametinib
1
talquetamab
1
taletrectinib
1
sotorasib
1
ruxolitinib
1
revumenib
1
omburtamab I-131
1
leronlimab
1
gallium maltolate
1
dabrafenib
1
ceritinib
1
capmatinib
1
asparaginase erwinia chrysanthemi recombinant
1
apalutamide
1
Standard of Care
1
Paclitaxel
1
Nivolumab
1
HMPL-013
1
Docetaxel
1
Asparaginase
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
No longer available
×
asparaginase erwinia chrysanthemi recombinant
×
1 year
×
Clear all
NCT00590915
2026-01-23
EMTP
Phoenix Children's Hospital
No longer available